Posted by Michael Wonder on 01 May 2026
Johnson & Johnson to offer four prescription medicines on TrumpRx website
24 April 2026 - Johnson & Johnson will start selling four of its medications on the Trump administration's TrumpRx website, the company told Reuters.
The company said it would begin offering its diabetes drugs Invokamet, Invokamet XR and Invokana, as well as blood thinner Xarelto, through the TrumpRx platform and its direct to consumer website, JNJ Direct.
